References
- Wiener AS, Unger LJ, Gordon EB. Fatal hemolytic transfusion reaction caused by sensitization to a new blood factor U. JAMA 1953;153:1444–6.
- Meltz DJ, Bertles JF, David DS, De Ciutiis AC. Delayed hemolytic transfusion reaction with renal failure. Lancet 1971;11:1348–9.
- Rothman IK, Alter HJ, Strewler GJ. Delayed overt hemolytic transfusion reaction due to anti-U antibody. Transfusion 1976;16:357–60.
- Mollison PL, Engelfriet CP, Contreras M, eds. Blood transfusion in clinical medicine. 9th ed. Oxford, England: Blackwell Scientific Publications, 1993:534.
- Issitt PD. Applied blood group serology. 3rd ed. Miami; Montgomery Scientific Publications, 1985:506.
- Croucher BEE, Crookston MC, Crookston JH. Delayed hemolytic transfusion reactions simulating autoimmune hemolytic anemia. Vox Sang 1967;12:32–42.
- Croucher BEE. Differential diagnosis of delayed transfusion reactions. In: Bell CA, ed. A seminar on laboratory management of hemolysis. Washington, DC: American Association of Blood Banks, 1979:151–60.
- Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990;30:688–93.
- Greenwalt TJ, Sasaki T. The Lutheran blood groups: a second example of anti-Lub and three further examples of anti-Lua. Blood 1957; 12:998–1003.
- Fudenberg H, Allen FH. Transfusion reactions in the absence of demonstrable incompatibility. NEJM 1957;256:1180–4.
- Kluge von A, Krah E, Franz HE. Cellano-sensibilisierung mit hemolytischehaemorrhagischem transfusionszwischenfall. Blut 1969;18:267–75.
- Gunson HH, Stratton F, Phillips PK. The use of modified cells to induce an anti-Rh response. Br J Haematol 1971;21:683–94.
- Patten E, Reddi CR, Riglin H, Edwards J. Delayed hemolytic transfusion reaction caused by a primary immune response. Transfusion 1982;22:248–50.
- Solanki D, McCurdy PR. Delayed hemolytic transfusion reactions, an often missed entity. JAMA 1978;239:729–31.
- Bacon N, Patten E, Vincent J. Primary immune response to blood group antigens in burned children. Immunohematology 1991;7:8–11.
- Cox MT, Roberts M, Lajoie J, Enfonde M, Kress D, Blumberg, N. An apparent primary immune response involving anti-Jka and anti-P1 detected 10 days after transfusion. Transfusion 1992;32:874.
- Davey RJ, Gustafson M, Holland PV. Accelerated immune red cell destruction in the absence of serologically detectable alloantibodies. Transfusion 1980;20:348–53.
- Harrison CR, Hayes TC, Trow LL, Benedetto AR. Intravascular hemolytic transfusion reaction without detectable antibodies: a case report and review of literature. Vox Sang 1986; 51:96–101.
- Baldwin ML, Barrasso C, Ness PM, Garratty G. A clinically significant erythrocyte antibody detectable only by 51Cr survival studies. Transfusion 1983;23:40–4.
- Hart MVD, Engelfriet CP, Prins HK, van Loghem JJ. A haemolytic transfusion reaction without demonstrable antibodies in vitro. Vox Sang 1963;8:363–70.
- Garratty G. Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology, 1989;5:97–106.
- McCall L, Owens M. Case report: hemolytic anemia produced by tolmetin. Immunohematology 1992;8:17–8.
- Jackson V, Josephson AM, Storry J, Futral D, Boudreau FT. A fatal case of tolmetin-induced immune hemolysis, disseminated intravascular coagulation, and acute renal failure (letter). Immunohematology 1992;8:79.
- Maddox NI, Futral D, Boudreau ET. Serologic investigation of fatal hemolytic anemia associated with a multiple drug history and Rh-like autoantibody. Immunohematology 1992:8:70–6.
- Keidan SE, Lohoar E, Mainwaring D. Acute anuria in a haemophiliac due to transfusion of incompatible plasma. Lancet 1966;1:179–82.
- Goldfinger D, Kleinman S, Connelly M, Chaux A, Sacks HJ. Acute hemolytic transfusion reaction (HTR) with disseminated intravascular coagulation (DIC) and acute renal failure (ARF) due to transfusion of plasma containing Rh antibodies (abstract). Transfusion 1979;19:639–40.
- Inwood MJ, Zuliani B. Anti-A hemolytic transfusion with packed O cells. Ann Intern Med 1978;89:515–6.
- Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion 1985;25:60–2.
- Schwartz JM, Cohn BD, Ritz ND, et al. Appendectomy in hemophilia with the use of cryoprecipitated human factor VIII to control bleeding. JAMA 1966; 198:1175–9.
- Rosati LA, Barnes B, Oberman HA, et al. Hemolytic anemia due to anti-A in concentrated antihemophilic factor preparations. Transfusion 1970; 10:139–41.
- Seeler RA. Hemolysis due to anti-A and anti-B in factor VIII preparations. Arch Intern Med 1972;130:101–3.
- Copelan EA, Strohm PL, Kennedy MS, Tutschka PJ. Hemolysis following intravenous immune globulin therapy. Transfusion 1986;26:410–2.
- Heddle NM, Kelton JG, Turchyn KL, Ali MAM. Hypergammaglobulinemia can be associated with a positive direct antiglobulin test, a nonreactive eluate, and no evidence of hemolysis. Transfusion 1988;28:29–33.
- Comenzo RL, Malachowski ME, Meissner R, et al. Immune hemolysis, disseminated intravascular coagulation and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr 1992;120:926–8.
- Swanson JL, Issitt CH, Mann EW, Condie RM, Simmons RL, McCullough J. Resolution of red cell compatibility testing problems in patients receiving anti-lymphoblast or antithymocyte globulin. Transfusion 1984;24:141–3.
- Anderson HJ, Aubuchon JP, Draper EK, et al. Transfusion problems in renal allograft recipients: anti-lymphocyte globulin showing Lutheran system specificity. Transfusion 1985;25:47–50.
- Aubert EF, Boorman KE, Dodd BE, Loutit JF. The universal donor with high titre iso-agglutinins: the effect of anti-A isoagglutinins on recipients of group A. Br Med J [Clin Res] 1942;1:659–64.
- Tisdall LH, Carland DM, Szanto PB, Hand AM, Bonnett JC. The effects of the transfusion of group O blood of high isoagglutinin titer into recipients of other blood groups. Am J Clin Pathol 1946; 16:193–206.
- Grove-Rasmussen M, Shaw RS, Marceau E. Hemolytic transfusion reaction in a group-A patient receiving group-O blood: containing immune anti-A antibodies in high titer. Am J Clin Pathol 1953;23:828–32.
- Ervin DM, Young LE. Dangerous universal donors I. Observations on destruction of recipient’s A cells after transfusion of group O blood containing a high titer of A antibodies of immune type not easily neutralizable by soluble A substance. Blood 1950;5:61–73.
- Issitt PD, Zellner DC, Rolih D, Duckett JB. Autoantibodies mimicking alloantibodies. Transfusion 1977;17:531–8.
- Issitt PD, Pavone BG. Critical re-examination of the specificity of auto-anti-Rh antibodies in patients with a positive direct antiglobulin test. Br J Haematology 1978;38:63–74.
- Sullivan CM, Kline WE, Rabin BI, Johnson CL, Marsh WL. The first example of autoanti-Kx. Transfusion 1987;27:322–4.
- Becton DL, Kinney TR. An infant girl with severe autoimmune hemolytic anemia: apparent anti-Vel specificity. Vox Sang 1986;51:108–11.
- Manny N, Levene C, Sela R, Johnson CL, Mueller KA, Marsh WL. Autoimmunity and the Kell blood groups: auto-anti-Kpb in aKp(a+b-) patient. Vox Sang 1983;45:252–6.
- Seyfried H, Gorska B, Maj S, Sylwestrowicz T, Giles CM, Goldsmith KLG. Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia. Vox Sang 1972;23:528–36.
- Beck ML, Marsh WL, Pierce SR, DiNapoli J, Øyen R, Nichols ME. Auto-anti-Kpb associated with weakened antigenicity in the Kell blood group system: a second example. Transfusion 1979; 19; 197–201.
- Nugent ME, Colledge KI, Marsh WL. Auto-immune hemolytic anemia caused by anti-U. Vox Sang 1971;20:519–25.
- Marsh WL, Reid ME, Scott EP. Autoantibodies of U blood group specificity in autoimmune hemolytic anemia. Br J Haematol 1972;22:625–9.
- Bove JR. Delayed complications of transfusion. Conn Med J 1968;32:36–9.
- Hillman NM. Fatal delayed hemolytic transfusion reaction due to anti-c + E. Transfusion 1979;19:548–51.
- Ramsey G. Red cell antibodies arising from solid organ transplants. Transfusion 1991;31:76–86.
- Petz LD. Immunohematologic problems associated with bone marrow transplantation. Transfus Med Rev 1987; 1:85–100.
- Lasky LC, Warkentin PI, Kersey JH, et al. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion 1983;23:277–85.
- Hunt BJ, Yacoub M, Amin S, et al. Induction of red blood cell destruction by graft-derived antibodies after minor ABO-mismatched heart and lung transplantation. Transplantation 1988;46:246–9.
- Perlman EJ, Shirey RS, Farkosh M, et al. Immune hemolytic anemia following heart-lung transplantation. Immunohematology 1992;8:38—40.
- Mangal AK, Growe GH, Sinclair M, et al. Acquired hemolytic anemia due to “auto” anti-A or “auto” anti-B induced by group O homograft in renal transplant recipients. Transfusion 1984;24:201–5.
- Solheim BG, Albrechtsen DA, Berg KJ, et al. Hemolytic anemia in cyclosporine-treated recipients of kidney or heart grafts from donors with minor incompatibility for ABO antigens. Transplant Proc 1987;19:4236–8.
- Albrechtsen D, Solheim BG, Flatmark A, et al. Autoimmune hemolytic anemia in cyclosporine-treated organ allograft recipients. Transplant Proc 1988;20:959–62.
- Orchard J, Young NT, Smith C, Thomas S, Darke C. Severe intravascular haemolysis in a renal transplant recipient due to anti-B of donor origin. Vox Sang 1990;59:172–5.
- Angstadt J, Jarrell B, Maddrey W, et al. Hemolysis in ABO incompatible liver transplantation. Transplant Proc 1987; 19:4595–7.
- Triuzli DJ, Shirey RS, Ness PM, Klein AS. Immunohematologic complications of ABO-unmatched liver transplants. Transfusion 1992;32:829–33.
- Ramsey G, Nusbacher J, Starzl TE, Lindsay GD. Isohemagglutinin of graft origin after ABO-unmatched liver transplantation. NEJM 1984;311:1167–70.
- Gordon RD, Iwatsuki S, Esquivel CO, et al. Experience with primary liver transplantation across ABO blood groups. Transplant Proc 1987;19:4575–9.
- Shanwell A, Eleboŗg L, Blomqvist BŁ, Wiechel B, Ericzon BG. Hemolysis in ABO-compatible liver transplantation—only after O grafts? Transplant Proc 1989;21:3532.
- Ramsey G, Cornell FW, Hahn LF, Larson P, Issitt LB, Starzl TE. Red cell antibody problems in 1000 liver transplants. Transfusion 1989;29:396–400.
- Jenkins RL, Georgi BA, Gallik-Karlson CA, Rohrer RJ, Khettry U, Dzik WH. ABO mismatch and liver transplantation. Transplant Proc 1987;19:4580–5.
- Salamon DJ, Ramsey G, Nusbacher J, Yang S, Starzl TE, Israel L. Anti-A production by a group O spleen transplanted to a group A recipient. Vox Sang 1985;48:309–12.
- Bevan PC, Seaman M, Tolliday B, Chalmers DG. ABO haemolytic anaemia in transplanted patients. Vox Sang 1985;49:42–8.
- Swanson JL, Sastamoinen RM, Steeper TA, Sebring ES. Gm allo typing to determine the origin of red cell antibodies in recipients of solid organ transplants. Vox Sang 1987;52:75–8.
- Swanson J, Sebring E, Sastamoinen R, Chopek M. Gm allotyping to determine the origin of the anti-D causing hemolytic anemia in a kidney transplant recipient. Vox Sang 1987;52:228–30.